Clinicians' Concepts of the Cognitive Deficits of Schizophrenia

Overview

Journal Schizophr Bull

Publisher Oxford University Press

Specialty Psychiatry

Date 2007 Apr 11

PMID 17420175

Citations 3

Authors

Elizabeth Bromley

Affiliations

Soon will be listed here.

Abstract

Several compounds to improve cognition in schizophrenia are being studied in clinical trials, but little is known about how clinicians conceptualize the cognitive deficits of schizophrenia. In a pilot study, the author asked 40 psychiatrists 3 brief questions about the clinical presentation of cognitive deficits. Descriptions of cognitive deficits show high variability. Informants describe phenomenology like follow-through, attention, and emptiness as indicative of cognitive impairment. Informants' concepts of cognitive deficits overlap substantially with positive, negative, and thought disorder symptoms. Clinicians' concepts are complex and contextualized, in contrast to the discrete skills measured by neuropsychological tests. Results suggest that appropriate prescribing of cognition-enhancing medications may be challenging.

Citing Articles

Evidence supporting the use of a brief cognitive assessment in routine clinical assessment for psychosis.

Cowman M, Lonergan E, Burke T, Bowie C, Corvin A, Morris D Schizophrenia (Heidelb). 2022; 8(1):113.

PMID: 36528607 PMC: 9759520. DOI: 10.1038/s41537-022-00322-z.

The Fracture of Relational Space in Depression: Predicaments in Primary Care Help Seeking.

Bromley E, Kennedy D, Miranda J, Sherbourne C, Wells K Curr Anthropol. 2016; 57(5):610-631.

PMID: 27990025 PMC: 5155333. DOI: 10.1086/688506.

Teaching critical thinking in psychiatric training: a role for the social sciences.

Bromley E, Braslow J Am J Psychiatry. 2008; 165(11):1396-401.

PMID: 18981073 PMC: 3096667. DOI: 10.1176/appi.ajp.2008.08050690.

References

Britten N, Jenkins L, Barber N, Bradley C, Stevenson F . Developing a measure for the appropriateness of prescribing in general practice. Qual Saf Health Care. 2003; 12(4):246-50. PMC: 1743739. DOI: 10.1136/qhc.12.4.246. View

Bromley E . Barriers to the appropriate clinical use of medications that improve the cognitive deficits of schizophrenia. Psychiatr Serv. 2007; 58(4):475-81. DOI: 10.1176/ps.2007.58.4.475. View

Keefe R, Goldberg T, Harvey P, Gold J, Poe M, Coughenour L . The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004; 68(2-3):283-97. DOI: 10.1016/j.schres.2003.09.011. View

Prouteau A, Verdoux H, Briand C, Lesage A, Lalonde P, Nicole L . Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophr Res. 2004; 69(1):85-91. DOI: 10.1016/j.schres.2003.08.011. View

Moritz S, Ferahli S, Naber D . Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. J Int Neuropsychol Soc. 2004; 10(4):623-33. DOI: 10.1017/S1355617704104153. View

Medalia A, Lim R . Self-awareness of cognitive functioning in schizophrenia. Schizophr Res. 2004; 71(2-3):331-8. DOI: 10.1016/j.schres.2004.03.003. View

Heinrichs R, Zakzanis K . Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998; 12(3):426-45. DOI: 10.1037//0894-4105.12.3.426. View

Nuechterlein K, Barch D, Gold J, Goldberg T, Green M, Heaton R . Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004; 72(1):29-39. DOI: 10.1016/j.schres.2004.09.007. View

Subotnik K, Nuechterlein K, Irzhevsky V, Kitchen C, Woo S, Mintz J . Is unawareness of psychotic disorder a neurocognitive or psychological defensiveness problem?. Schizophr Res. 2005; 75(2-3):147-57. DOI: 10.1016/j.schres.2004.12.005. View

10.

Lorenz K, Ryan G, Morton S, Chan K, Wang S, Shekelle P . A qualitative examination of primary care providers' and physician managers' uses and views of research evidence. Int J Qual Health Care. 2005; 17(5):409-14. DOI: 10.1093/intqhc/mzi054. View

11.

Bromley E . A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project. Schizophr Bull. 2005; 31(4):954-61. DOI: 10.1093/schbul/sbi059. View

12.

Srinivasan L, Tirupati S . Relationship between cognition and work functioning among patients with schizophrenia in an urban area of India. Psychiatr Serv. 2005; 56(11):1423-8. DOI: 10.1176/appi.ps.56.11.1423. View

13.

Cole M, McCusker J, Elie M, Dendukuri N, Latimer E, Belzile E . Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial. CMAJ. 2005; 174(1):38-44. PMC: 1319344. DOI: 10.1503/cmaj.050519. View

14.

Keefe R, Poe M, Walker T, Kang J, Harvey P . The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry. 2006; 163(3):426-32. DOI: 10.1176/appi.ajp.163.3.426. View

15.

Subotnik K, Nuechterlein K, Green M, Horan W, Nienow T, Ventura J . Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients. Schizophr Res. 2006; 85(1-3):84-95. DOI: 10.1016/j.schres.2006.03.007. View

16.

Harvey P, Green M, Bowie C, Loebel A . The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology (Berl). 2006; 187(3):356-63. DOI: 10.1007/s00213-006-0432-1. View

17.

Marder S, Fenton W, Youens K . Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative. Am J Psychiatry. 2004; 161(1):25. DOI: 10.1176/appi.ajp.161.1.25. View